Provide advisory for the all value chains including R&D, New launch effectiveness, and GxP/Quality
Unmet medical needs are increasing worldwide. Especially, therapeutic areas for Cancer (Solid tumor and Hematology), Vaccines and Immunotherapy for Infectious Diseases, Auto-immune diseases, Rare-diseases are becoming important health and economic burdens
Glorialth provides advisory especially around 1) Investment/Acquisition /BD, 2) Product, 3) Regulatory and Health Policy, 4) Care of R&D/New Launch, 5) Science Technology / IP, 6) Japan expert
Provide advisory for combined opportunity with Pharmaceutical Medicines, Vaccines, and Therapies
Most of elderly diseases develop through the interaction of genetic makeup and environmental factors. Based on genetic data and history of the early environment, it is able to be delineated high-risk group and intervene before disease onset. It can be supported by predictive biomarkers, too.
Precision and pre-emptive medicines are thus a hallmark of public health, and their combination use with Pharmaceuticals/Therapies can provide blue ocean business opportunity
Provide advisory for business opportunity of Regenerative medicine, Well-aging products
Specialty care/cure can be a business bordery with precision medicine, care/cure, and/or preventing diseases, and thus would be consulted
Glorialth provides advisory especially for their business opportunity of Regenerative medicine, High end of well-aging products
To be discussed further what can be advised in each specific care/cure case upon the needs
Copyright © GloriaLTH All Rights Reserved
